Trial Profile
Effects of Tocilizumab (RoACTEMRA) on Biomarkers in Synovial Tissue of Patients with Rheumatoid Arthritis.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2017
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 07 Jun 2011 New trial record